The European Hematology Association (EHA), a HARMONY Alliance Partner, will be attending the 5th Educational Conference of the Haematology Nurses and Healthcare Professional Group (HNHCP) in Zürich (January 10–11, 2020).
Robin Doeswijk of the EHA’s Medical Affairs Team will be attending the meeting to speak about how HARMONY’s Big Data initiative is helping to transform the medical landscape of several hematologic malignancies and discuss how to get involved. Contact us today if you would like to arrange a one-to-one meeting with Robin.
The HNHCP is global organization dedicated to the education of the nursing community to optimize the delivery of care to individuals living with hematologic malignancies. The 5th Educational Conference will present updates on recent scientific developments and clinical management practices in hematology and oncology. Click here to visit the official HNHCP website.
The HARMONY Alliance is a European public–private partnership that is capturing and mining Big Data on seven different hematologic malignancies with the aim of accelerating the development of more effective treatments. The data is stored in HARMONY’s Big Data Platform, for 45 000 anonymized patient records have been identified to date, making it one of the largest databases of its kind. Leading research teams are currently using this wealth of information to answer critical questions about hematologic malignancies that cannot be addressed with other methods. Learn more about HARMONY and our research projects.
See what other meetings HARMONY is holding and attending by visiting our meetings page.
Become involved with HARMONY today! Contact us to find out how you can participate in ongoing and future research initiatives.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
